Abortifacient (Major drug group)

January 2002
Royal Society of Medicine: Medicines;2002, p27
Reference Entry
This article presents information on abortifacients, in which drugs are used to induce abortion or miscarriage as a medical alternative to surgical termination. A number of types of drug have been used to procure therapeutic abortion, but commonly the progestogen hormone antagonist drug is used and/or a prostaglandin, dinoprostone by pessary. A variety of other synthetic or natural agents, and certain microbial toxins, may cause abortion.


Related Articles

  • Unborn Child's Death Leads to Jail for Father. TOWNSEND, LIZ // National Right to Life News;May2009, Vol. 36 Issue 5, p10 

    The article reports on the conviction of Airman Scott Boie for attempting to kill his unborn child. Boie was sentenced on May 2, 2009 of over nine years in prison, a dishonorable discharge and forfeiture of all benefits due him. Boie, who wanted his wife to have an abortion, was found to have...

  • Mifepristone and misoprostol in termination of pregnancy.  // American Family Physician;11/1/1993, Vol. 48 Issue 6, p1152 

    Reports on the two studies by Peyron and colleagues concerning the efficacy of oral prostaglandin E1 derivative misoprostol in combination with antiprogestin mifepristone in termination of pregnancy. Publication of article in the May 27, 1993 issue of the `New England Journal of Medicine';...

  • Options for Early Therapeutic Abortion. Bygdeman, Marc; Danielsson, Kristina G. // Drugs;2002, Vol. 62 Issue 17, p2459 

    Vacuum aspiration, either manual or electric, has for many years been the most commonly used method for termination of an early pregnancy. More recently, new medical methods have been developed which for many women are attractive alternatives to the surgical procedure. The compounds mainly used...

  • Editor's Choice. van Steirteghem, André // Human Reproduction;May2010, Vol. 25 Issue 5, p1087 

    The article discusses various reports that are published within this issue, including the use of mifeprestone and prostaglandin for medical abortion, the risk of miscarriage in overweight and obese women, and the gene expression pattern of human spermatogonia.

  • Abortion does not raise risk of breast cancer, US study finds. Tanne, Janice Hopkins // BMJ: British Medical Journal (International Edition);5/5/2007, Vol. 334 Issue 7600, p923 

    This article examines a large U.S. study which found that neither induced abortion nor miscarriage increases the risk of breast cancer. Anti-abortion groups in the U.S. have claimed that having an abortion increases a woman's risk of getting breast cancer and they use the argument to help...

  • Therapeutic abortions, 1998.  // Health Reports;Feb2001, Vol. 12 Issue 2, p60 

    Presents statistics on therapeutic abortions in Canada in 1998. Number of therapeutic abortions obtained by Canadian women; Decrease in the number of therapeutic abortions compared to 1997; Canadian provinces and territories which saw a decline in the number of therapeutic abortions.

  • Comparison of two doses and two routes of administration of misoprostol after pre-treatment with mifepristone for early pregnancy termination. von Hertzen, Helena; Piaggio, Gilda; Marions, Lena // Reproductive Health;2008, Vol. 5, Special section p1 

    Background: It is not known whether a 400 µg dose of misoprostol has a similar efficacy as an 800 µg dose when administered sublingually or vaginally 24 hours after 200 mg mifepristone. Methods: It is proposed to undertake a placebo-controlled, randomized, non-inferiority trial (3% margin...

  • Self - Prescribed Contraceptive Education by the Unwillingly Pregnant. Thiebaux, H. Jean // American Journal of Public Health;May1972, Vol. 62 Issue 5, p689 

    With change of legal status for therapeutic abortion and the consequent development of special-purpose medical facilities, pregnancy counseling services have greatly expanded, providing a resource of inestimable value for the etiology of unwanted pregnancy. Here it is used to define modes for...

  • Questions raised about mifepristone manufacturer.  // Contraceptive Technology Update;Apr2008, Vol. 29 Issue 4, p39 

    The article reports on the effect of mifepristone to patients seeking medication abortion in the U.S.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics